Identification of clinically important chromosomal aberrations in acute myeloid leukemia by array-based comparative genomic hybridization

Leukemia and Lymphoma

Volumn 55, Issue 11, 2014, Pages 2538-2548

  Mehrotra, Meenakshi ^a   Luthra, Rajyalakshmi ^a   Ravandi, Farhad ^a   Sargent, Rachel L ^a   Barkoh, Bedia A ^a   Abraham, Ronald ^a   Mishra, Bal Mukund ^a   Jeffrey Medeiros, L ^a   Patel, Keyur P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

AML; Array comparative genomic hybridization; Chromosome regions 5q and 17p; RNF145; TP53

Indexed keywords

CYTARABINE; IDARUBICIN; MICRORNA; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DELETION 17; CHROMOSOME DELETION 5; CHROMOSOME IDENTIFICATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; KARYOTYPING; LEUKEMIA REMISSION; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; ACUTE DISEASE; CHROMOSOME 17; CHROMOSOME 5; COPY NUMBER VARIATION; DRUG ADMINISTRATION; GENETICS; KAPLAN MEIER METHOD; KARYOTYPE; LEUKEMIA, MYELOID; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOLOGY; PROCEDURES; PROGNOSIS; REMISSION;

ACUTE DISEASE; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 5; COMPARATIVE GENOMIC HYBRIDIZATION; CYTARABINE; DNA COPY NUMBER VARIATIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IDARUBICIN; KAPLAN-MEIER ESTIMATE; KARYOTYPE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REMISSION INDUCTION;

EID: 84912080883     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.883073     Document Type: Article

References (28)

1. Bajaj R, Xu F, Xiang B, et al. Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia. Mol Cytogenet 2011;4:3.
2. Chen CC, Yang CF, Lee KD, et al. Complex karyotypes confer a poor survival in adult acute myeloid leukemia with unfavorable cytogenetic abnormalities. Cancer Genet Cytogenet 2007;174:138-146.
3. Nahi H, Lehmann S, Bengtzen S, et al. Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia. Leuk Lymphoma 2008; 49: 508-516.
4. Veigaard C, Norgaard JM, Kjeldsen E. Genomic prof ling in high hyperdiploid acute myeloid leukemia: a retrospective study of 19 cases. Cancer Genet 2011;204:516-521.
5. Casas S, Aventin A, Fuentes F, et al. Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia. Cancer Genet Cytogenet 2004;153:16-25.
6. Rabin KR, Man TK, Yu A, et al. Clinical utility of array comparative genomic hybridization for detection of chromosomal abnormalities in pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008;51:171-177.
7. Schoch C, Haferlach T, Bursch S, et al. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and f uorescence in situ hybridization including 24-color FISH. Genes Chromosomes Cancer 2002;35:20-29.
8. Shinawi M, Cheung SW. The array CGH and its clinical applications. Drug Discov Today 2008;13:760-770.
9. Oostlander AE, Meijer GA, Ylstra B. Microarray-based comparative genomic hybridization and its applications in human genetics. Clin Genet 2004;66:488-495.
10. Bejjani BA, Shafer LG. Application of array-based comparative genomic hybridization to clinical diagnostics. J Mol Diagn 2006; 8: 528-533.
11. Paulsson K, Heidenblad M, Strombeck B, et al. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration. Leukemia 2006;20:840-846.
12. Suela J, Alvarez S, Cigudosa JC. DNA prof ling by arrayCGH in acute myeloid leukemia and myelodysplastic syndromes. Cytogenet Genome Res 2007; 118: 304-309.
13. Slovak ML, Smith DD, Bedell V, et al. Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromes. Mol Cytogenet 2010;3:23.
14. Walter MJ, Payton JE, Ries RE, et al. Acquired copy number alterations in adult acute myeloid leukemia genomes. Proc Natl Acad Sci USA 2009;106:12950-12955.
15. Costa AR, Belangero SI, Melaragno MI, et al. Additional chromosomal abnormalities detected by array comparative genomic hybridization in AML. Med Oncol 2012;29:2083-2087.
16. Yasar D, Karadogan I, Alanoglu G, et al. Array comparative genomic hybridization analysis of adult acute leukemia patients. Cancer Genet Cytogenet 2010;197:122-129.
17. Sargent R, Jones D, Abruzzo LV, et al. Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic prof ling of chronic lymphocytic leukemia. J Mol Diagn 2009;11:25-34.
18. Ma D, Chen Z, Patel KP, et al. Array comparative genomic hybridization analysis identif es recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk 2011; 11(Suppl. 1): S17-S24.
19. Cheung SW, Shaw CA, Scott DA, et al. Microarray-based CGH detects chromosomal mosaicism not revealed by conventional cytogenetics. Am J Med Genet A 2007;143A:1679-1686.
20. Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000;96:4075-4083.
21. Rucker FG, Schlenk RF, Bullinger L, et al. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood 2012;119:2114-2121.
22. Evers C, Beier M, Poelitz A, et al. Molecular Definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH. Genes Chromosomes Cancer 2007;46:1119-1128.
23. Streford JC, Worley H, Barber K, et al. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene 2007; 26: 4306-4318.
24. Liao D. Emerging roles of the EBF family of transcription factors in tumor suppression. Mol Cancer Res 2009; 7: 1893-1901.
25. Lukin K, Fields S, Hartley J, et al. Early B cell factor: regulator of B lineage specification and commitment. Semin Immunol 2008; 20:221-227.
26. Jerez A, Sugimoto Y, Makishima H, et al. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood 2012;119:6109-6117.
27. Jerez A, Gondek LP, Jankowska AM, et al. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. J Clin Oncol 2012;30:1343-1349.
28. Cuneo A, Bigoni R, Cavazzini F, et al. Incidence and signif cance of cryptic chromosome aberrations detected by f uorescence in situ hybridization in acute myeloid leukemia with normal karyotype. Leukemia 2002; 16: 1745-1751.